New patch could ease agitation in Alzheimer's patients
NCT ID NCT06052254
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a medicated skin patch (dexmedetomidine) to see if it can reduce agitation in people with Alzheimer's dementia. About 150 participants living in care facilities will receive either the patch or a placebo for 96 hours. The goal is to measure changes in agitated behavior using a standard scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BioBehavioral Health
RECRUITINGToms River, New Jersey, 08755, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Elixia MA, LLC
WITHDRAWNSpringfield, Massachusetts, 01103, United States
-
Vitalix
RECRUITINGWorcester, Massachusetts, 01608, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.